Monocytes at the crossroads of aortic stenosis and myocardial damage
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvaf186 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Nervana Issa und 11 weiteren Autor:innen. Beteiligte Einrichtung: UR UPJV 7517 MP3CV, CURS, Université de Picardie Jules Verne, Avenue René Laennec, Amiens 80054, France. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Monocytes, Aortic Valve, Myocardium. Die Arbeit nennt 209 Literaturangaben.
Abstract (Originalsprache)
Aortic stenosis (AS) is the most common heart valve disease in high-income countries, causing significant morbidity and mortality. It results from progressive thickening and calcification of the aortic valve (AV) leaflets, leading to AV narrowing and myocardial remodeling—both key contributors to disease progression and symptoms. With no pharmacological treatment to slow AS, aortic valve replacement (AVR) remains the only therapeutic option for symptomatic patients. However, limited understanding of AS pathophysiology and the absence of reliable prognostic markers hinder improved patient outcomes. A comprehensive reassessment of AS pathophysiology, integrating both valvular and myocardial remodeling is essential for advancing prognostic tools and therapeutic strategies. Inflammation plays a central role in these processes, drawing increasing attention to monocytes. This review provides an updated overview of monocytes’ multifaceted involvement in AS, including: (i) fibrocalcific remodeling of the valve, (ii) myocardial injury during disease progression, and (iii) structural valve deterioration (SVD) after surgical or transcatheter AVR. We will also discuss the potential of monocyte subsets as biomarkers for AS progression and post-AVR prognosis, as well as the therapeutic targeting of monocytes to prevent AS, SVD, and subsequent myocardial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UR UPJV 7517 MP3CV, CURS, Université de Picardie Jules Verne, Avenue René Laennec, Amiens 80054, France.
- Department of Nephrology, Amiens University Hospital, Amiens 80054, France.
- Nantes Université, CHU Nantes, CNRS, INSERM, L'institut du Thorax, Nantes F-44000, France.
- UR4666, HEMATIM, UPJV, Amiens 80054, France.
- Service d'Hématologie Clinique et de Thérapie Cellulaire, Amiens University Hospital, Amiens 80054, France.
- Translational Cardiology, Department of Medicine Solna, Karolinska Institutet and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Romain Capoulade, Magnus Bäck, Sylvain Fraineau, Youssef Bennis, Christophe Tribouilloy, Lucie Hénaut
Zitieren
APA
Issa, N., Candellier, A., Boudot, C., Capoulade, R., Ghamlouch, H., Bäck, M., Fraineau, S., Bennis, Y., Eltchaninoff, H., Kamel, S., Tribouilloy, C., & Hénaut, L. (2025). Monocytes at the crossroads of aortic stenosis and myocardial damage. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf186
Vancouver
Issa N, Candellier A, Boudot C, Capoulade R, Ghamlouch H, Bäck M, et al. Monocytes at the crossroads of aortic stenosis and myocardial damage. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf186
BibTeX
@article{Issa2025,
author = {Issa, Nervana and Candellier, Alexandre and Boudot, Cédric and Capoulade, Romain and Ghamlouch, Hussein and Bäck, Magnus and Fraineau, Sylvain and Bennis, Youssef and Eltchaninoff, Hélène and Kamel, Saïd and Tribouilloy, Christophe and Hénaut, Lucie},
title = {Monocytes at the crossroads of aortic stenosis and myocardial damage},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvaf186}
}
EUVIMED